DocSym
β
Searchsearch
Search
(I42.4) Endocardial fibroelastosis
More details coming soon
7 490 884 in individuals diagnosis endocardial fibroelastosis confirmed
1 748 898 deaths with diagnosis endocardial fibroelastosis
23% mortality rate associated with the disease endocardial fibroelastosis
Diagnosis endocardial fibroelastosis is diagnosed Men are 33.91% more likely than Women
5 015 509
Men receive the diagnosis endocardial fibroelastosis
937 319 (18.7 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
2 475 375
Women receive the diagnosis endocardial fibroelastosis
811 579 (32.8 %)Died from this diagnosis.
Risk Group for the Disease endocardial fibroelastosis - Men aged 60-64 and Women aged 75-79
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features endocardial fibroelastosis
Absence or low individual and public risk
Endocardial fibroelastosis - what does this mean
Endocardial fibroelastosis is a rare disorder of the heart that is caused by an abnormal thickening and stiffening of the endocardium, the innermost layer of the heart. this thickening and stiffening of the endocardium can lead to a decrease in the amount of blood that is able to be pumped out of the heart, resulting in heart failure.
What happens during the disease - endocardial fibroelastosis
Endocardial fibroelastosis is a rare disorder of the heart caused by abnormal thickening of the endocardium, the inner lining of the heart. this thickening can lead to impaired function of the heart valves, leading to a decreased ability to pump blood through the heart. this can result in an increased risk of arrhythmias, congestive heart failure, and other cardiovascular complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Echocardiogram
- Electrocardiogram (ECG)
- Chest X-ray
- Cardiac MRI
- Cardiac catheterization
- Blood tests
- Heart biopsy
- Echocardiographic tissue Doppler imaging
- Exercise stress testing
Treatment and Medical Assistance
Main Goal: To improve the patient's symptoms and reduce the risk of complications.
- Administering medications to reduce symptoms and improve heart function.
- Monitoring the patient's vital signs and other indicators of heart health.
- Performing regular echocardiograms to monitor the progress of the disease.
- Providing lifestyle recommendations to reduce risk factors, such as quitting smoking and maintaining a healthy weight.
- Performing heart surgery to correct any structural defects in the heart.
- Administering oxygen therapy to improve oxygen delivery to the heart.
- Providing nutritional counseling to ensure adequate nutrition.
- Performing regular exercise to strengthen the heart muscle.
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Endocardial fibroelastosis - Prevention
Endocardial fibroelastosis is a rare heart condition that can be prevented through lifestyle modifications such as maintaining a healthy diet, exercising regularly, avoiding smoking, and controlling high blood pressure. additionally, regular monitoring and management of any existing heart conditions is important to reduce the risk of developing this condition.